TDG Form 4: Director awarded 518 options; vesting starts 9/30/2026
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
TransDigm Group (TDG) — Form 4: Director Gary McCullough reported a grant of stock options on 11/04/2025. The award covers 518 options to purchase common stock at an exercise price of $1,291.97 per share, expiring on 11/04/2035. The filing lists 518 derivative securities beneficially owned following the transaction, held direct.
Per the footnote, the options vest 20% per year over five years beginning September 30, 2026, and are subject to annual operating performance targets.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
MCCULLOUGH GARY E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 518 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 518 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did TransDigm (TDG) disclose in this Form 4?
A director, Gary McCullough, was granted 518 stock options on 11/04/2025 at an exercise price of $1,291.97.
What is the vesting schedule for the TDG options?
They vest 20% per year for five years starting on September 30, 2026, subject to annual operating performance targets.
What is the expiration date of the options reported by TDG?
The options expire on 11/04/2035.
How many derivative securities are held after the transaction?
The filing shows 518 derivative securities beneficially owned following the transaction.
What is the ownership form of the reported TDG options?
The ownership form is listed as Direct (D).
Who is the reporting person in this TDG Form 4?
The filing is for Gary McCullough, identified as a Director.